Morris D Groves
US Oncology Research, McKesson Specialty Health · M.D. Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Morris D Groves as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:23 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT02000882 · STAR Cape+BKM120 MBC With Brain MetUS Oncology Research · completed · Brain Metastases, Breast Cancer, Metastatic Breast Cancer · principal investigator
- Ph1/Ph2NCT01217411 · RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast CancerNational Cancer Institute (NCI) · terminated · Adult Solid Neoplasm, Extensive Stage Lung Small Cell Carcinoma, HER2/Neu Negative · principal investigator
- Ph1NCT00515788 · DepoCyt Plus Temozolomide in Patients With Neoplastic MeningitisM.D. Anderson Cancer Center · terminated · Neoplastic Meningitis · principal investigator
- Ph1NCT00512460 · RTA 744 Injection in Patients With Leptomeningeal DiseaseM.D. Anderson Cancer Center · terminated · Neoplastic Meningitis, Solid Tumor, Lymphoma · principal investigator
- Ph1NCT00508456 · Dietary Methionine Restriction Plus Temozolomide for Recurrent GBMM.D. Anderson Cancer Center · terminated · Glioblastoma Multiforme · principal investigator
- Ph2NCT00227656 · Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast CancerM.D. Anderson Cancer Center · terminated · Breast Cancer, Metastatic Cancer · principal investigator
- Ph2NCT00006358 · Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain TumorSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Brain and Central Nervous System Tumors · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Experimental Medicine ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FUNDA MERIC-BERNSTAM · fiscal years 2013 to 2026Named on NCT01217411
- Phase I Studies of Targeted Anti-Cancer TherapiesU01CA062461 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI James C Yao · fiscal years 2013Named on NCT01217411
- Phase I Clinical Trials of Anti-Cancer AgentsU01CA069852 · NCI · UNIVERSITY OF CHICAGO · PI MARK J RATAIN · fiscal years 2013Named on NCT01217411
- Phase I Trials of Anti-Cancer AgentsU01CA076576 · NCI · OHIO STATE UNIVERSITY · PI MICHAEL R GREVER · fiscal years 2013Named on NCT01217411
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:23 UTC. The ranking covers the 200 most relevant of 28 PubMed records, and a shared surname and initials can bring in a namesake. All 28 on PubMed
- A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.Neuro Oncol · 2015345 citationsRCR 10.5
- Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.Clin Cancer Res · 2006319 citationsRCR 7.0
- Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.Nat Med · 2023275 citationsRCR 24.2
- Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors.J Clin Oncol · 2012270 citationsRCR 6.5
- Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme.J Clin Oncol · 2002188 citationsRCR 4.1
- Phase I study of GRN1005 in recurrent malignant glioma.Clin Cancer Res · 2013153 citationsRCR 4.8
- Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02.Neuro Oncol · 2014139 citationsRCR 4.0
- A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor.J Neurooncol · 2012112 citationsRCR 3.8
- 111 citationsRCR 2.6
- A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies.Neuro Oncol · 2008103 citationsRCR 2.6